5. Drug-coated balloons

Drug-coated balloon treatment in patients with high-bleeding risk

DEBUT
Objective
to investigate whether drug coated balloon-only treatment (with possibility to bailout stenting) was safe and effective compared to PCI with bare metal stents
Study
investigator-initiated randomised single blind multicentre non-inferiority trial (margin 3% difference)
Population
risk factors for bleeding: use oral anticoagulants, age >80 years, anaemia, thrombocytopenia, malignancy, previous stroke or bleeding, severe renal dysfunction, hepatic failure, planned surgery, substantial frailty, previous significant bleeding included patients with stable angina or ACS with expected simple PCI procedure
Endpoints
MACE at 9 months
Conclusion
treatment of simple coronary lesions with drug-coated balloon was superior to bare metal stents in patients at a high-bleeding risk
Rissanen et al. Lancet. 2019;394:230-9
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved